ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

ACS Creates $1 Billion Nationwide Organization, Taking Fiduciary Control From 12 Divisions

November 18, 2011

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002

Jackson Lab Win $9.5 Mil. Grant; Others Named

October 5, 1990

Rauscher Labels With Congress, Says NCI Needs More Money

May 2, 1975

DCPC Developing Hispanic Cancer Control Intervention Program Concept

August 12, 1988

Sponsors Wanted: FDA Offers Incentives For Pediatric Oncology Drug Development.

March 10, 2000